Binge eating disorder research hub

Open label, single-center, two-part pharmacokinetic study: Part I: Relative bioavailability study to compare the pharmacokinetics of BP1.4979 after administration of single oral doses of BP1.4979 as sustained release formulation and actual immediate release formulation, under fasting and fed conditions, in healthy subjects. Part II: Pharmacokinetics of BP1.4979 after a 14-day dosing period with b.i.d. administration of BP1.4979 as sustained release formulation in healthy subjects.

This study looks at how a new medicine, BP1.4979, works in healthy people. We want to see how the body absorbs, uses, and gets rid of the medicine when taken in different ways, specifically if it's a slow-release tablet or a quick-release one.

Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder

This study is looking into whether a medication called hydrocortisone can help reduce strong cravings for food in people with Binge Eating Disorder. It aims to see if participants feel less craving when faced with real food a few days after treatment.

Effectiveness of Group EFT for Transdiagnostic Eating Disorders/Difficulties Within Student Counselling Services.

This study looks at how well group therapy called Emotion-Focused Therapy (EFT) works for students with eating problems at university counselling services. We want to see if it's a good way to help students feel better and improve their mental health.

Efficacy of Juniver, a Digital Self-help Intervention, on Symptoms of Eating Disorders: A Randomised Controlled Trial

This study is testing a new iPhone app called Juniver for people with eating disorders. It's a digital self-help program with tools, learning, and peer support. Researchers want to see if it helps reduce eating disorder symptoms and improves well-being.

A double-blind, placebo-controlled pilot trial of BP1.4979 for the treatment of binge eating disorder.